Products

St. Jude Medical, Inc. today announced the U.S. launch of its Attune™ Flexible Adjustable Annuloplasty Ring for the repair of diseased heart valves.

Medtronic, Inc. today announced U.S. Food and Drug Administration approval and availability of the Attain Ability® left-heart lead (Model 4196) for use with cardiac resynchronization therapy devices for heart failure patients.

Amedica Corporation announced that it has received a CE mark for initial rollout of their spinal intervertebral spacers using novel CSC (cancellous-structured ceramic) technology.

CoreSpine Technologies announced today it has received 510(k) clearance to market from the U.S. Food and Drug Administration for its XTEND-ST™ Nucleus Removal System.

Medtronic, Inc. today announced the U.S. launch of the PEEK PREVAIL™ Cervical Interbody Device.

The Society of Cardiovascular Angiography and Interventions will highlight Cardiac Dimensions®, Inc.’s AMADEUS™ study during its 32nd annual scientific sessions held in Las Vegas, NV later this week.

X-spine Systems, an emerging manufacturer of implants and instruments for spinal surgery, announces FDA clearance of its new Calix spinal implant system.

Despite the common perception that total hip replacements last about 10 years, researchers at Rush University Medical Center have found that the devices are extremely durable, even 20 years after surgery.

SensAble Technologies, Inc® announced that its customer GMV is showcasing an expanded set of touch-enabled features in a major new version of its insightArthroVR® arthroscopic knee and shoulder surgery simulator at this week’s Arthroscopy Association of North America (AANA) annual meeting in San Diego.

Stryker Corp. won’t achieve a ninth straight year of double-digit sales growth this year, the company’s chief executive officer told Stryker shareholders Wednesday.

Citing weak global markets, Smith & Nephew PLC reported a 5 percent decline in revenues for the first quarter of 2009, falling from $911 million in the year-ago quarter to $865 million.

DePuy Spine, Inc. announced the launch of HEALOS® Fx Injectable Bone Graft Replacement (HEALOS Fx), the company’s first bone graft solution designed specifically for minimally invasive spine surgery (MIS).

Cardica, Inc. today announced that it is seeking to expand beyond the field of cardiac surgery and into additional surgical markets with the development of a potentially revolutionary, true multi-fire endoscopic linear microcutter based on proprietary technology developed at Cardica.

MAKO Surgical Corp. today announced that Ivan Delevic has been appointed to the newly created position of Senior Vice President of Strategic Marketing and Business Development.

STO Technologies, Inc. announced today that it has received notification from the U.S. Food and Drug Administration allowing the company to proceed with a Phase I clinical study for NuQu™, a cell-based injectable formulation of juvenile chondrocytes designed to regenerate cartilage, restore disc function and relieve discogenic back pain.

W. L. Gore & Associates today announced the May 4, 2009 availability of a 31 mm diameter version of the GORE EXCLUDER® AAA Endoprosthesis. The device provides physicians with a safe and effective endovascular option to treat abdominal aortic aneurysms in patients with aortic inner neck diameters up to 29 mm.